Evaluation of mRNA transcript levels using DDPCR for the assessment of early cell populations and single-cell clones in cell line development
CL202601233A1Pending Publication Date: 2026-07-24AMGEN INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CL202601233
- Authority / Receiving Office
- CL · CL
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-10-17
- Filing Date
- 2026-04-16
- Publication Date
- 2026-07-24
Abstract
This disclosure relates to the field of cell culture technology. It provides a method for facilitating the selection of a single-cell clone or cell populations for the production of an antigen-binding protein with two to four different antibody chains. The method uses ddPCR for the quantification of transcription levels.
Need to check novelty before this filing date? Find Prior Art